Evidence map›Paper›PMID 35446896›Full record

ArticlePloS one2022

Sharing datasets of the COVID-19 epidemic in the Czech Republic.

Martin Komenda, Jiří Jarkovský, Daniel Klimeš, Petr Panoška, Ondřej Šanca, Jakub Gregor, Jan Mužík, Matěj Karolyi, Ondřej Májek, Milan Blaha and 6 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 6 institutions in 1 country.

Martin KomendaInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.ORCID 0000-0003-0572-5767
Jiří JarkovskýInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Daniel KlimešInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Petr PanoškaInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Ondřej ŠancaInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Jakub GregorInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.ORCID 0000-0003-2431-7873
Jan MužíkInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Matěj KarolyiInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Ondřej MájekInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.ORCID 0000-0002-0034-3084
Milan BlahaInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Barbora MackováNational Institute of Public Health, Prague, Czech Republic.ORCID 0000-0003-1409-1671
Jarmila RážováMinistry of Health of the Czech Republic, Prague, Czech Republic.
Věra AdámkováDepartment of Preventive Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Vladimír ČernýDepartment of Anaesthesiology, Perioperative Medicine and Intensive Care, Masaryk Hospital in Ústí nad Labem, Ústí nad Labem, Czech Republic.
Jan BlatnýMinistry of Health of the Czech Republic, Prague, Czech Republic.
Ladislav DušekInstitute of Health Information and Statistics of the Czech Republic, Prague, Czech Republic.
Masaryk University · CZMinistry of Health · CZCharles University · CZInstitute of Health Information and Statistics · CZJan Evangelista Purkyně University in Ústí nad Labem · CZNational Institute of Public Health · CZ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

At the time of the COVID-19 pandemic, providing access to data (properly optimised regarding personal data protection) plays a crucial role in providing the general public and media with up-to-date information. Open datasets also represent one of the means for evaluation of the pandemic on a global level. The primary aim of this paper is to describe the methodological and technical framework for publishing datasets describing characteristics related to the COVID-19 epidemic in the Czech Republic (epidemiology, hospital-based care, vaccination), including the use of these datasets in practice. Practical aspects and experience with data sharing are discussed. As a reaction to the epidemic situation, a new portal COVID-19: Current Situation in the Czech Republic (https://onemocneni-aktualne.mzcr.cz/covid-19) was developed and launched in March 2020 to provide a fully-fledged and trustworthy source of information for the public and media. The portal also contains a section for the publication of (i) public open datasets available for download in CSV and JSON formats and (ii) authorised-access-only section where the authorised persons can (through an online generated token) safely visualise or download regional datasets with aggregated data at the level of the individual municipalities and regions. The data are also provided to the local open data catalogue (covering only open data on healthcare, provided by the Ministry of Health) and to the National Catalogue of Open Data (covering all open data sets, provided by various authorities/publishers, and harversting all data from local catalogues). The datasets have been published in various authentication regimes and widely used by general public, scientists, public authorities and decision-makers. The total number of API calls since its launch in March 2020 to 15 December 2020 exceeded 13 million. The datasets have been adopted as an official and guaranteed source for outputs of third parties, including public authorities, non-governmental organisations, scientists and online news portals. Datasets currently published as open data meet the 3-star open data requirements, which makes them machine-readable and facilitates their further usage without restrictions. This is essential for making the data more easily understandable and usable for data consumers. In conjunction with the strategy of the MH in the field of data opening, additional datasets meeting the already implemented standards will be also released, both on COVID-19 related and unrelated topics.

Indexed as

COVID-19Czech RepublicHumansInformation DisseminationPandemicsSARS-CoV-2

Identifiers

PMID35446896
PMCPMC9022808
OpenAlexW4224240295

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.